CA2326351A1 - Systeme prothetique - Google Patents
Systeme prothetique Download PDFInfo
- Publication number
- CA2326351A1 CA2326351A1 CA002326351A CA2326351A CA2326351A1 CA 2326351 A1 CA2326351 A1 CA 2326351A1 CA 002326351 A CA002326351 A CA 002326351A CA 2326351 A CA2326351 A CA 2326351A CA 2326351 A1 CA2326351 A1 CA 2326351A1
- Authority
- CA
- Canada
- Prior art keywords
- vertebrae
- graft material
- bone graft
- prosthesis
- hollow interior
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 claims abstract description 27
- 230000004927 fusion Effects 0.000 claims abstract description 25
- 230000033001 locomotion Effects 0.000 claims abstract description 18
- 210000000845 cartilage Anatomy 0.000 claims abstract description 5
- 238000007790 scraping Methods 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims description 93
- 210000000988 bone and bone Anatomy 0.000 claims description 89
- 125000006850 spacer group Chemical group 0.000 claims description 45
- 238000003780 insertion Methods 0.000 claims description 23
- 230000037431 insertion Effects 0.000 claims description 23
- 239000003351 stiffener Substances 0.000 claims description 15
- 230000008468 bone growth Effects 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 12
- 238000001356 surgical procedure Methods 0.000 claims description 10
- 230000007423 decrease Effects 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 239000003102 growth factor Substances 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 238000004873 anchoring Methods 0.000 claims description 5
- 238000005728 strengthening Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 4
- 230000004936 stimulating effect Effects 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 10
- 239000002904 solvent Substances 0.000 description 7
- 230000012010 growth Effects 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000008733 trauma Effects 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000001054 cortical effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 229920000049 Carbon (fiber) Polymers 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002870 angiogenesis inducing agent Substances 0.000 description 2
- 239000004917 carbon fiber Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical group C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 102000003712 Complement factor B Human genes 0.000 description 1
- 108090000056 Complement factor B Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 102000014429 Insulin-like growth factor Human genes 0.000 description 1
- 208000008457 Neurologic Manifestations Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000004918 carbon fiber reinforced polymer Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000003049 inorganic solvent Substances 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000001045 lordotic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000921 morphogenic effect Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000009251 neurologic dysfunction Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000004820 osteoconduction Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 229910000811 surgical stainless steel Inorganic materials 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Prostheses (AREA)
- Surgical Instruments (AREA)
Abstract
L'invention concerne un procédé chirurgical permettant d'insérer un système prothétique entre une première et une seconde vertèbre (V1-V2) espacées par un disque, de manière à limiter le mouvement entre ces première et seconde vertèbres, ainsi qu'à faciliter leur fusion. Ce procédé consiste à mettre à nu les première et seconde vertèbres et le disque, à exciser au moins une partie du disque entre les première et seconde vertèbres, et à racler le cartilage des surfaces en regard des vertèbres afin de mettre à nu ces surfaces en regard. Ce procédé consiste également à espacer les première et seconde vertèbres par une distance sélectionnée, et simultanément à ménager des sillons dans les surfaces en regard des vertèbres au moyen d'un outil de coupe comportant des lames opposées. Une prothèse mécanique (30) est fixée dans les sillons ménagés dans les surfaces en regard des vertèbres pour que la prothèse s'étende entre les vertèbres et qu'elle limite le mouvement entre celles-ci.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5049898A | 1998-03-30 | 1998-03-30 | |
| US09/050,498 | 1998-03-30 | ||
| PCT/US1999/003907 WO1999049818A1 (fr) | 1998-03-30 | 1999-02-23 | Systeme prothetique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2326351A1 true CA2326351A1 (fr) | 1999-10-07 |
Family
ID=21965576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002326351A Abandoned CA2326351A1 (fr) | 1998-03-30 | 1999-02-23 | Systeme prothetique |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1066001A1 (fr) |
| AU (1) | AU741664B2 (fr) |
| CA (1) | CA2326351A1 (fr) |
| ZA (1) | ZA992225B (fr) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5425772A (en) * | 1993-09-20 | 1995-06-20 | Brantigan; John W. | Prosthetic implant for intervertebral spinal fusion |
| US5571189A (en) * | 1994-05-20 | 1996-11-05 | Kuslich; Stephen D. | Expandable fabric implant for stabilizing the spinal motion segment |
| FR2728159B1 (fr) * | 1994-12-16 | 1997-06-27 | Tornier Sa | Prothese discale elastique |
-
1999
- 1999-02-23 AU AU29732/99A patent/AU741664B2/en not_active Ceased
- 1999-02-23 EP EP99910983A patent/EP1066001A1/fr not_active Withdrawn
- 1999-02-23 CA CA002326351A patent/CA2326351A1/fr not_active Abandoned
- 1999-03-19 ZA ZA9902225A patent/ZA992225B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU741664B2 (en) | 2001-12-06 |
| ZA992225B (en) | 2000-12-19 |
| AU2973299A (en) | 1999-10-18 |
| EP1066001A1 (fr) | 2001-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6413278B1 (en) | Prosthetic system | |
| US6835208B2 (en) | Prosthetic system | |
| US12484945B2 (en) | System for sacroiliac joint fusion | |
| EP3406226B1 (fr) | Système d'implant vertébral | |
| EP3634280B1 (fr) | Système d'implant rachidien | |
| EP3174504B1 (fr) | Système d'implant rachidien | |
| EP3174486B1 (fr) | Implant rachidien | |
| EP3981365B1 (fr) | Système d'implant d'ostéotomie intracorporel vertébral | |
| AU2019210628B2 (en) | Spinal implant system and method | |
| US20140180418A1 (en) | Device For Securing An Implant To Tissue | |
| US20110218627A1 (en) | System and method for replacing at least a portion of a vertebral body | |
| US12575938B2 (en) | Spinal implant system and method | |
| JP2018516620A (ja) | 脊椎インプラントシステム及び使用方法 | |
| US20200054460A1 (en) | Intrabody Osteotomy Implant and Methods of Use | |
| US20180104072A1 (en) | Surgical instrument system and method | |
| CN105392434A (zh) | 脊柱构造和方法 | |
| AU741664B2 (en) | Prosthetic system | |
| CN113164194A (zh) | 外科植入物及其使用方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |